This trial is testing whether lengthening the infusion time for paclitaxel normalizes levels of the drug in patients with low muscle mass.
1 Primary · 2 Secondary · Reporting Duration: Up to week 12
Active Control
Experimental Treatment
22 Total Participants · 2 Treatment Groups
Primary Treatment: Paclitaxel · No Placebo Group · Phase 4
Age 18+ · Female Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: